Sinopia Biosciences
The AI engine Fit Assessment
BetaSinopia Biosciences effectively leverages machine learning and multi-omics data to discover new patterns and expand therapeutic options, optimizing the drug discovery process.
Blurb
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
HQ Location
San Diego (United States)
Founded
2014
Employees
1 - 10
Total funding raised
$16.61M
Funding Status
Grant, $2.20M, September 12, 2024
Subspaces
- Drug Discovery Optimization
Sinopia Biosciences, Inc. is a clinical-stage biotechnology company advancing novel therapeutics derived from its proprietary computational drug discovery platform. Sinopia’s proprietary computational platform combines high-throughput omics data, machine learning, and network biology. Sinopia is headquartered at JLABS San Diego.